Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

Marwan N. Sabbagh,Seol Heui Han,Sangyun Kim,Hae Ri Na,Jae-Hong Lee,Nagaendran Kandiah,Kammant Phanthumchinda,Chuthamanee Suthisisang,Vorapun Senanarong,Ming-Chyi Pai,Diatri Narilastri,Ajit M. Sowani,Encarnita Ampil,Amitabh Dash

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

2016

Marwan N. Sabbagh
Seol Heui Han
Sangyun Kim
Hae Ri Na
Jae-Hong Lee
Nagaendran Kandiah
Kammant Phanthumchinda
Chuthamanee Suthisisang
Vorapun Senanarong
Ming-Chyi Pai
Diatri Narilastri
Ajit M. Sowani
Encarnita Ampil
Amitabh Dash

Background: The ‘Asia-Pacific Expert Panel (APEX) for donepezil 23 mg' met in November 2015 to review evidence for the recently approved high dose of donepezil an

Keywords:

Physical therapy
Dementia
Psychiatry
Disease
Donepezil
Medicine
Internal medicine
asia pacific region
moderate to severe
disease progression

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations